Traders assign an 82.5% probability to no new COVID variant of concern being designated before 2027 because current surveillance shows no SARS-CoV-2 lineages meeting WHO or ECDC VOC criteria as of mid-2026. Subvariants such as BA.3.2 (Cicada), NB.1.8.1, and XFG circulate at low overall prevalence in the United States and elsewhere, with risk assessments remaining low due to limited evidence of enhanced transmissibility, immune escape, or severity. Genomic monitoring through wastewater, traveler surveillance, and clinical sequencing continues to detect Omicron descendants, but none have triggered escalation in the past several months. The short window until year-end further reduces the chance of rapid emergence and formal designation, aligning with the stable, low-risk landscape reflected in recent public health reports.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano$242,200 Wol.
$242,200 Wol.
$242,200 Wol.
$242,200 Wol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Rynek otwarty: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...Traders assign an 82.5% probability to no new COVID variant of concern being designated before 2027 because current surveillance shows no SARS-CoV-2 lineages meeting WHO or ECDC VOC criteria as of mid-2026. Subvariants such as BA.3.2 (Cicada), NB.1.8.1, and XFG circulate at low overall prevalence in the United States and elsewhere, with risk assessments remaining low due to limited evidence of enhanced transmissibility, immune escape, or severity. Genomic monitoring through wastewater, traveler surveillance, and clinical sequencing continues to detect Omicron descendants, but none have triggered escalation in the past several months. The short window until year-end further reduces the chance of rapid emergence and formal designation, aligning with the stable, low-risk landscape reflected in recent public health reports.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania